Searchable abstracts of presentations at key conferences on calcified tissues
Bone Abstracts (2013) 1 PP178 | DOI: 10.1530/boneabs.1.PP178


Bone-marrow mesenchymal stem cells (MSCs) are the origin of bone-forming cells with immunomodulation potential. Among the generated immunosuppressive molecules there is HLA-G5. HLA-G proteins play a crucial role in promoting the acceptance of allografts. However, the mechanisms regulating the expression of HLA-G5 in human MSCs are unknown. We induced differentiation of human MSCs (harvested from iliac crests of healthy volunteers after their informed consent following approved Ethical Local Committee of Tours Hospital) and found that HLA-G5 was greatly upregulated only in osteoblastic cells (+63% for mRNA). Growth plates and bone callus post-fracture in adults showed that only bone lining cells and mesenchymal progenitors were positive for HLA-G5. Use of gene silencing and dominant-negative factors revealed that HLA-G5 depends on the expression and function of the skeletogenesis master genes RUNX2 and DLX5. In addition, HLA-G5 could directly inhibit osteoclastogenesis by acting on monocytes through SHP1. However, in mature osteoblasts, the expression of HLA-G5 protein was greatly suppressed (above 100% suppression) whereas the pro-osteoclastogenic factor, RANKL, was concomitantly increased. Downregulation of HLA-G5 expression during the maturation of osteoblasts was due to binding of the repressor GLI3, a signal transducer of the Hedgehog pathway, to the GLI binding element within the HLA-G promoter. Our findings show that bone tissue specifically expresses HLA-G5, with a key role in bone homeostasis.

Volume 1

European Calcified Tissue Society Congress 2013

Lisbon, Portugal
18 May 2013 - 22 May 2013

European Calcified Tissue Society 

Browse other volumes

Article tools

My recent searches

No recent searches.